Prostatis Group’s Dow Inc DOW Stock Holding History

Prostatis Group’s Portfolio DOW Stock Details DOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,277	Closed	-$783K	–	140
2023 Q4	$783K	Sell	14,277 -438	-3%	-$22.4K	0.33%	71
2023 Q3	$749K	Sell	14,715 -526,553	-97%	-$28.3M	0.37%	57
2023 Q2	$627K	Buy	+541,268	New	+$28.8M	0.29%	67

Other funds holding DOW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Prostatis Group's DOW Position: Q1 2024 in Review

Prostatis Group sold out of Dow Inc (DOW) in Q1 2024, closing a stake of 14,277 shares — an estimated $783K sold.

Prostatis Group first reported a position in DOW in Q2 2023 and held it in 3 quarters. The position peaked at $783K in Q4 2023. 1,609 funds tracked by Wall St. Rank hold DOW as of Q1 2024.

Prostatis Group reported no remaining Dow Inc position as of Q1 2024 after selling out during the quarter.
Prostatis Group sold 14,277 Dow Inc shares in Q1 2024, an estimated $783K.
Prostatis Group first reported a position in Dow Inc in Q2 2023 and held it in 3 quarters.
Prostatis Group's Dow Inc position peaked at $783K in Q4 2023.
1,609 funds tracked by Wall St. Rank held Dow Inc as of Q1 2024.

Based on Prostatis Group's 13F filing for Q1 2024, filed 21 Mar 2025.